Earli's Vision for Revolutionizing Cancer Detection
SHARON SIM • January 30, 2025

Earli is transforming early cancer detection and treatment by bioengineering cancer cells to reveal and destroy themselves. Developed at the intersection of biology, engineering, and software, this platform answers the critical question — “Is it cancer? Y/N” — while enabling targeted therapeutic applications, paving the way for a new era in cancer care.
Earli’s innovative work was recently featured in Medical Newspaper (Bosa), where CEO Cyriac Roeding shared insights on Korea and Japan’s leadership in early detection. Their groundbreaking advancements continue to push the field forward, an effort SKC is proud to support.
Read more: Full Article on Bosa
Latest Blogs

By SHARON SIM
•
December 10, 2025
Breaking into U.S. media isn’t just about showing up, it’s about playing by the rules of a new playground. At SKC, we help Asian brands turn strategy, storytelling, and timing into coverage that sticks. With the right partner, clear expectations, and cultural insight, your pitches don’t just get seen, they earn real tr








